NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wheeler Bio

Wheeler Bio

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://wheelerbio.com/

Last Round

Series A

Extension

Mar 20, 2025

Total Funding Raised

$80M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Wheeler Bio is a biomanufacturing company that provides contract development and manufacturing organization (CDMO) services to accelerate the transition of therapeutic innovations into clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMObiologics manufacturingcontract developmentcGMP manufacturingprocess developmentanalytical developmentbiopharma outsourcingclinical-stage manufacturingCMC serviceschemistry manufacturing and controlstechnology transferbiotech manufacturingdrug development servicesbiologics scale-upbiotech partner

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wheeler Bio Comps

Public and private peers based on sector, stage, and business model.

Wheeler Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wheeler Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 20, 2025
Series AApr 13, 2023
SeedJan 4, 2022

Key People

Founding team and executive leadership

Jay Benson

Chief Operating Officer

Executive Team

Wheeler Bio Investors

Notable investors and investment history

Wheeler Bio investors
InvestorRounds
Floating PointSeed
Atum CapitalSeries A
Germin8 VenturesSeries A Extension
Floating Point AdvisorsSeries A, Seed
Plains VenturesSeries A
Russell Westbrook EnterprisesSeries A Extension
Presbyterian Health FoundationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors grew 35% MoM, from 2.1K to 2.9K.

  • Oct 7, 2025

    Jay Benson joins as the new Chief Operating Officer.

Wheeler Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wheeler Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wheeler Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range73
Year Founded2020
Last FundingMar 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.